MORGAN STANLEY - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 180 filers reported holding BRIDGEBIO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$38,185,342
+301.2%
1,448,060
+161.7%
0.00%
+300.0%
Q2 2023$9,518,702
-37.2%
553,413
-39.5%
0.00%
-50.0%
Q1 2023$15,167,234
+88.5%
914,791
-13.4%
0.00%
+100.0%
Q4 2022$8,045,477
-20.9%
1,055,837
+3.1%
0.00%0.0%
Q3 2022$10,176,000
-16.0%
1,023,814
-23.3%
0.00%
-50.0%
Q2 2022$12,118,000
+3.2%
1,334,460
+15.3%
0.00%0.0%
Q1 2022$11,743,000
+78.5%
1,156,938
+193.3%
0.00%
+100.0%
Q4 2021$6,579,000
-36.1%
394,487
+79.7%
0.00%0.0%
Q3 2021$10,288,000
-56.4%
219,509
-43.3%
0.00%
-66.7%
Q2 2021$23,616,000
-13.6%
387,418
-12.6%
0.00%
-25.0%
Q1 2021$27,320,000
+417.9%
443,502
+497.8%
0.00%
+300.0%
Q4 2020$5,275,000
+493.4%
74,185
+213.1%
0.00%
Q3 2020$889,000
-54.2%
23,691
-60.2%
0.00%
Q2 2020$1,941,000
+198.6%
59,517
+165.5%
0.00%
Q1 2020$650,000
-51.6%
22,415
-41.4%
0.00%
Q4 2019$1,342,000
+625.4%
38,270
+345.6%
0.00%
Q3 2019$185,000
-76.9%
8,588
-71.1%
0.00%
Q2 2019$801,00029,7000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders